COVID-19 trials registries data warehouse

http://ensaiosclinicos.gov.br/rg/RBR-97nt6j

Arnoldo Souza

arnoldos@cardiol.br

2020-09-24

Not recruiting

RCT

Randomized

Parallel

Open label

multi-center

Treatment

Man and women Age between 18 and 90 years, Signature of the informed consent form (ICF). COVID-19 positive PCR (Swab) exam

Pregnancy, especially in the beginning, Individuals who continuously use immunosuppressants or have been transplanted for less than 6 months, Individuals participating in other clinical studies. Symptoms of severe acute respiratory syndrome (SARS) and / or comorbidities according to the regulations of the Ministry of Health (Guidelines for Diagnosis and Treatment for COVID-19, version 1 of April 6, 2020), with suspicion of COVID-19, with Covid RT-PCR -19

2

Associação Brasileira de Ozonioterapia

18

90

Brazil

Mild/moderate disease at enrollment

2: Mild/moderate disease at enrollment

0

Reduction in the percentage of patients with suspected / confirmed COVID 19 who evolve to more severe forms (need for hospitalization and / or mechanical ventilation) with an increase in the recovery rate of these patients in the group who underwent ozone therapy.

Phase 1/Phase 2

[{"arm_notes": "", "treatment_id": 952, "treatment_name": "Ozone therapy", "treatment_type": "Others non pharmacological treatment", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]